Clinical studies have demonstrated the key role of PPARG in tumorigenesis and development in various types of tumors, including BC, liver cancer, lung cancer, and neurological tumors, through the inhibition of cancer cell proliferation or the promotion of cancer cell apoptosis and autophagy. Here, PPARG is linked to lung carcinoma.